Cue Biopharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cue Biopharma and other ETFs, options, and stocks.About CUE
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its pipeline includes Immuno-oncology, CUE-100 framework, CUE-200 framework, and autoimmune disease.
CEODaniel R. Passeri
CEODaniel R. Passeri
Employees41
Employees41
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2014
Founded2014
Employees41
Employees41
CUE Key Statistics
Market cap48.90M
Market cap48.90M
Price-Earnings ratio-1.07
Price-Earnings ratio-1.07
Dividend yield—
Dividend yield—
Average volume289.67K
Average volume289.67K
High today$0.799
High today$0.799
Low today$0.7391
Low today$0.7391
Open price$0.78
Open price$0.78
Volume47.30K
Volume47.30K
52 Week high$2.26
52 Week high$2.26
52 Week low$0.45
52 Week low$0.45
CUE News
TipRanks 2d
Cue Biopharma announces common stock, warrant offering, no amount givenCue Biopharma (CUE) announced that it is commencing an underwritten public offering of shares of its common stock and accompanying warrants to purchase shares o...